Results

Total Results: 3,091 records

Showing results for "drugs".

381. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=442
     January 01, 2024 - Utilization Hakkarainen TW , Steele SR , Bastaworous A Nonsteroidal anti-inflammatory drugs … evaluated the association between the administration of postoperative non-steroidal anti-inflammatory drugs … Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington State's

382. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=432
     January 01, 2024 - hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs … of this study was to compare hospitalization rates after the initiation of different anti-arrhythmic drugs … hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs

383. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=482
     January 01, 2024 - by 2020, Medicare Part D enrollees with critical diseases such as AMI who rely heavily on brand name drugs … are likely to exhibit modest increases in adherence, while those reliant on generic drugs are less likely … Paediatr Drugs 2013 Dec;15(6):441-7. doi: 10.1007/s40272-013-0042-4. .

384. Study Recommends Training Community Pharmacists on Opioid Safety, Drug Monitoring Programs | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletter/e-newsletter/628.html
     August 01, 2018 - which are state-specific electronic databases that contain regularly updated patient data for scheduled drugs

385. Improving Healthcare Safety by Enhancing Medication Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
     September 30, 2024 - Purpose: Characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … : This project generated new epidemiologic evidence of patient safety risks and adverse events for drugs … at school led the Center to prepare a fact sheet, “Psychotropic Drugs and Children: Use, Trends, and … When evaluating new drugs for confusability, researchers believe the output of computerized drug name … , neuropsychiatry drugs, and drugs for other rare diseases.

386. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=4
     January 01, 2024 - , Sibley A Motivation and context of concurrent stimulant and opioid use among persons who use drugs … Semi-structured interviews with 349 people who use drugs (PWUD) in rural U.S. areas revealed a high prevalence … Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural … study was to examine the effects of interruptions in insurance coverage on purchases of prescription drugs

387. Final Progress Report: Reducing Adverse Drug Events From Anticoagulants, Diabetes Agents and Opioids in Primary Care (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/wessell2-report.pdf
     January 01, 2024 - medication in PPRNet CQMs (e.g., antidepressants, antihypertensives, nonsteroidal anti-inflammatory drugs … clinical quality measures (e.g., antidepressants, antihypertensives, nonsteroidal anti-inflammatory drugs

388. Final Progress Report: Epidemiology, Exploration, and Evaluation: Addressing potentially dangerous medications in children on Medicaid with a mental health diagnosis (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/kleinman-report.pdf
     January 01, 2024 - In each year studied, 38-40% of members who had BMHRx were taking two or more behavioral health drugs … Filled in 2014, Cohort vs BH Rx Only: By Drug Class Percent of Kids Taking BH Drugs Filled in 2014 … In 2014, there were 15 drugs that were prescribed without an appropriate diagnosis for at least 50% … Of those 15 drugs, seven were prescribed to fewer than 30 children. … Drugs Ther Perspect (2019) 35: 447. https://doi.org/10.1007/s40267-019-00650-8 4.

389. Blood Thinner Pills: Your Guide to Using Them Safely | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/btpills.html
     March 01, 2023 - Blood thinner drugs work well when they are used correctly. … When you visit your doctor, bring a list of current medicines, over-the-counter drugs—such as aspirin—and

390. More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/infographics/ed-visits-opioids.html
     September 01, 2021 - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment  (PDF, 587.7 KB) Emergency department (ED) visits for opioid-related diagnoses grew by an average of 12.3% per year, 2014-2017, but access to treatment …

391. Using Technology to Alert Clinicians to Potential Allergy, Drug Interactions | Agency for Healthcare Research and Quality
     www.ahrq.gov/funding/grantee-profiles/grtprofile-zhou.html
     July 01, 2024 - Grantee Profile Using Technology to Alert Clinicians to Potential Allergy, Drug Interactions Li Zhou, M.D., Ph.D. Professor of Medicine, Harvard Medical School Lead investigator, Brigham and Women’s Hospital Li Zhou, M.D., Ph.D. “I really appreciate how AHRQ looks for ways to use technology to improve patie…

392. Adverse Drug Events Occurring in U.S. Hospitals | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/infographics/adverse-drug-events.html
     August 01, 2018 - Adverse Drug Events Occurring in U.S. Hospitals Adverse Drug Events Occurring in U.S. Hospitals (PDF, 1.5 MB) Source:   HCUP Statistical Brief #164: Characteristics of Adverse Drug Events Originating During the Hospital Stay, 2011

393. Decarbonization Primer Developed To Help Healthcare Organizations Reduce Carbon Footprint | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/832.html
     September 01, 2022 - contributing to greenhouse gas emissions in healthcare: building energy; transportation; anesthetic gas; pharmaceuticals … AHRQ in the Professional Literature Medicaid and accelerated approval: spending on drugs with and without

394. AHRQ Signals Intent To Fund Clinics To Improve Care for People With Long COVID | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/852.html
     February 01, 2023 - The Drug Safety study provided details on drugs known to interact with colchicine, as well as management

395. Synthetic Healthcare Database for Research Getting Started Guide (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Getting-Started-Guide-rev.pdf
     June 01, 2022 - • Synthetic diagnoses, procedures, and drugs were generated so that univariate distributions of these … element in the synthetic data generation process, the frequencies of synthetic diagnoses, procedures, and drugs … While these differences are usually small, they may be pronounced for rare diseases, procedures, or drugs … diagnosis code than the first three characters), rare procedures beyond the CCS category level, and rare drugs

396. Synthetic Healthcare Database for Research Getting Started Guide (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Getting-Started-Guide.pdf
     May 01, 2022 - • Synthetic diagnoses, procedures, and drugs were generated so that univariate distributions of these … element in the synthetic data generation process, the frequencies of synthetic diagnoses, procedures, and drugs … While these differences are usually small, they may be pronounced for rare diseases, procedures, or drugs … diagnosis code than the first three characters), rare procedures beyond the CCS category level, and rare drugs

397. National Academy of Medicine (NAM) Reports | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/reports/national-academy-medicine.html
     February 01, 2018 - given week four out of every five U.S. adults will use prescription medicines, over-the-counter (OTC) drugs

398. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
     August 25, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

399. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
     August 13, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

400. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
     January 01, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.